HTDS - Hard To Treat Diseases Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HTDS - Hard To Treat Diseases

HTDS 0.000001000

-95.0%

May 28 12:33 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jmhollen	12/5/2004 11:14:59 PM
	of 271

From: Taki of 140214 On monitor,HTDS.014x.016.Alert,cancer drug Tubercin,test results any day from now to middle of December per last news.Time is getting close.A rally soon IMO. Read bold,from last news. TESTING: The testing being conducted at the Denver Veteran’s Affairs Medical Center and the University of Colorado Health Science Center is ahead of schedule. The testing began 7/1/04 and the agreement calls for a formal report of results after six months. We can only release the fact that the results have been more than favorable and HTTD is expecting a formal report of testing results by mid December. The testing results will be released as soon as HTTD receives them. HTTD has continued to test Tubercin® in FDA approved facilities under FDA guidelines. HTTD has and will continue to pay for this testing. We are all aware of the tremendous results of administering Tubercin® to patients in South Korea. Our goal with Tubercin® has not changed; to aggressively advance the testing of Tubercin® in the U.S., make strategic decisions and to be involved in negotiations with major drug firms within 18 months. .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next